AstraZeneca first-in-class ovarian cancer drug wins EU approval
December 18, 2014 at 02:40 AM EST
LONDON, Dec 18 (Reuters) - AstraZeneca's all-important cancer drug business received a fillip on Thursday as a new medicine against ovarian cancer was approved in Europe, making it the first of its kind to reach the market.